• Home
  • About us
    • Mission
    • The Board’s Presentation
  • News
    • What’s New on CytoPrevent
    • Board’s Position Papers
  • Guidelines & Regulations
  • Resources
    • Studies
    • Videos
    • Useful Links
  • Events
    • Congresses
  • Contact
Hazardous Drug Safety: Clarifying the confusion about closed systems

Hazardous Drug Safety: Clarifying the confusion about closed systems

by CytoPrevent | Sep 26, 2022 | What’s new on CytoPrevent

Seth Eisenberg (Professional Practice Coordinator, Infusion Services, Seattle Cancer Care Alliance)     Hazardous Drugs Risks associated with exposure to hazardous drugs (HDs) such as chemotherapy, have been well documented over the past two decades and...
ISOPP Standards for the Safe Handling of Cytotoxics

ISOPP Standards for the Safe Handling of Cytotoxics

by CytoPrevent | Aug 31, 2022 | What’s new on CytoPrevent

ISOPP Standards for the Safe Handling of Cytotoxics   Since the initial release of the International Society of Oncology Pharmacy Practitioners (ISOPP) Standards for the Safe Handling of Cytotoxic Drugs in 2007, much has evolved in oncology pharmacy. Safe...
EP calls for action: strengthening Europe in the fight against cancer

EP calls for action: strengthening Europe in the fight against cancer

by CytoPrevent | Jan 11, 2022 | What’s new on CytoPrevent

Press Release of the European Parliament   On 9 December 2021, Parliament’s Special Committee on Beating Cancer adopted its final proposals on how to strengthen the EU’s role in the fight against cancer. They include the following:   1. Taking stronger EU...
Stop Cancer at Work Campaign welcomes progress made in protecting workers from cancer and reproductive problems at work

Stop Cancer at Work Campaign welcomes progress made in protecting workers from cancer and reproductive problems at work

by CytoPrevent | Dec 30, 2021 | What’s new on CytoPrevent

Press Release – 16 December 2021   The Stop Cancer at Work Campaign today welcomes the provisional political agreement by the European Parliament and European Council to include for the first time greater protection and reference to reprotoxic substances...
WHO – Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings

WHO – Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings

by CytoPrevent | Dec 26, 2021 | What’s new on CytoPrevent

Background The toxic effects of antineoplastic drugs used for cancer treatment have been well known since their introduction in the 1940s. However, beyond the patient safety concerns arising from the necessary therapeutic use of these drugs, the occupational risks to...
EU to improve protection of workers from dangerous chemical substances

EU to improve protection of workers from dangerous chemical substances

by CytoPrevent | Dec 22, 2021 | What’s new on CytoPrevent

Official Press Release from the Council Presidency and the European Parliament   The Council presidency and the European Parliament have reached a provisional deal to update the carcinogens and mutagens directive, an EU law to protect workers from risks related...
« Older Entries

Legal Mentions

Cookies Policy

Contact Us


Follow us on Twitter

ESMO

 

Loading Comments...